Publications found:
241
Sort by:
The 2027-2032 World Outlook for Lou Gehrig's Disease Drugs
US$ 1,195.00
... study covers the world outlook for Lou Gehrig's Disease drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for Lou Gehrig's Disease drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
Global Narcolepsy Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... Market Segment by Applications, can be divided into Daytime Extreme Sleepiness Cataplexia Others There are 15 Chapters to deeply display the global Narcolepsy Drug market. Chapter 1, to describe Narcolepsy Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Narcolepsy Drug, with ...
January 2026
77 pages
Global Perphenazine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... from 95 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Perphenazine in global market, especially in North America, Europe ... growth rate by type, application, from 2014 to 2019. Chapter 12, Perphenazine market forecast, by regions, type and application, with ...
January 2026
100 pages
Global Neuromyelitis Optica Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... manufacturers of Neuromyelitis Optica Drug, with price, sales, revenue and global market share of Neuromyelitis Optica Drug in 2017 and 2018. Chapter 3, the Neuromyelitis Optica Drug competitive situation, sales, revenue and global market share ...
January 2026
116 pages
The 2027-2032 World Outlook for CNS Therapeutics
US$ 1,195.00
This study covers the world outlook for CNS therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
288 pages
Sleep Disorder Treatment Market - Forecast from 2026 to 2031
US$ 3,950.00
The sleep disorder treatment market is forecasted to achieve a 10.23% CAGR, reaching USD 35.666 billion in 2031 from USD 19.878 billion in 2025. The sleep disorder treatment market is witnessing risin...
January 2026
148 pages
Gabapentin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Form (Tablet, Capsule, Oral Solution), By Type (Generic, Branded), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Gabapentin Market, valued at USD 2.04 Billion in 2024, is projected to experience a CAGR of 5.60% to reach USD 2.83 Billion by 2030. Gabapentin, an anticonvulsant medication, is primarily u...
December 2025
185 pages
Autism Spectrum Disorders Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medication, Others), By Application (Autistic Disorder, Asperger Syndrome, Pervasive Development Disorder, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Autism Spectrum Disorders Treatment Market, valued at USD 1.71 Billion in 2024, is projected to experience a CAGR of 5.39% to reach USD 2.34 Billion by 2030. The Global Autism Spectrum Diso...
December 2025
185 pages
U.S. Autism Spectrum Disorder Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Antipsychotic Drugs, Stimulants, Sleep Medications, Selective Serotonin Reuptake Inhibitors), By Application, By Distribution Channel, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
The U.S. autism spectrum disorder treatment market size was estimated at USD 827.84 million in 2024 and is projected to reach USD 1,431.60 million by 2033, growing at a CAGR of 6.30% from 2025 to 2033...
November 2025
120 pages
Insomnia Drug Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Others), By Application (Over-the- Counter Drugs, Prescription Drugs), By Distribution Channel
US$ 3,950.00
The Insomnia Drug Market is valued at USD 2.95 billion in 2025 and is projected to grow at a CAGR of 5.1% to reach USD 4.62 billion by 2034. Insomnia Drug Market The Insomnia Drug market spans prescri...
November 2025
160 pages
Benzodiazepine Drugs Market Size, Share & Trends Analysis Report By Application (Anxiety Disorders, Insomnia & Sleep Disorders), By Product (Diazepam, Lorazepam, Alprazolam, Clonazepam), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global benzodiazepine drugs market size was estimated at USD 2.83 billion in 2024 and is projected to reach USD 3.85 billion by 2033, growing at a CAGR of 3.48% from 2025 to 2033. The industry is...
November 2025
150 pages
Benzodiazepine Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Alprazolam, Diazepam, Lorazepam, Clonazepam, Temazepam, Oxazepam, Chlordiazepoxide, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Application, By End User
US$ 3,950.00
The Benzodiazepine Drugs Market is valued at USD 4.5 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 8.5 billion by 2034.The benzodiazepine drugs market remains a critical comp...
October 2025
160 pages
Anti-Parkinson Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drugs Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs ), By Route of Administration (Oral, Injection, Transdermal ), By Distribution Channel
US$ 3,950.00
The Anti-Parkinson Drugs Market is valued at USD 9.4 billion in 2025 and is projected to grow at a CAGR of 7.3% to reach USD 17.7 billion by 2034.The Anti-Parkinson Drugs Market focuses on medications...
October 2025
160 pages
Generic Central Nervous System Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other Types), By Drug Classification (Branded Drugs, Generic Drugs), By Disease, By Route Of Administration, By Mode Of Purchase, By Distribution Channel
US$ 3,950.00
The Generic Central Nervous System Drugs Market is valued at USD 78.4 billion in 2025 and is projected to grow at a CAGR of 7.5% to reach USD 149.7 billion by 2034. Generic Central Nervous System Drug...
October 2025
160 pages
Grand Mal Seizure Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Barbiturates, Hydantoin, Phenyltriazine, Iminostilbenes, Benzodiazepines, Aliphatic Carboxylic Acids, Other Types), By Diagnosis (Magnetic Resonance Imaging (MRI), Electroencephalogram (EEG), Blood Tests, Computed Tomography (CT), Other Diagnosis), By Treatment, By End Users
US$ 3,950.00
The Grand Mal Seizure Treatment Market is valued at USD 2.7 billion in 2025 and is projected to grow at a CAGR of 5.2% to reach USD 4.2 billion by 2034. Grand Mal Seizure Treatment Market Overview The...
October 2025
160 pages
Headache Disorders Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse Headache, Other Types), By Treatment (Medication, Heat Therapy, Diet Changes, Acupuncture, Oxygen Therapy), By Diagnosis, By Route Of Administration, By End-User
US$ 3,950.00
The Headache Disorders Market is valued at USD 6 billion in 2025 and is projected to grow at a CAGR of 6.6% to reach USD 10.7 billion by 2034.The headache disorders market continues to gain prominence...
October 2025
160 pages
Sedative-Hypnotic Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes), By Route of Administration (Oral, Parenteral, Other Routes of Administration), By Disease Type, By Distribution Channel, By End-Users
US$ 3,950.00
The Sedative-Hypnotic Drugs Market is valued at USD 4.8 billion in 2025 and is projected to grow at a CAGR of 7.6% to reach USD 9.3 billion by 2034.The Sedative-Hypnotic Drugs market includes medicati...
October 2025
160 pages
Global Mental Illness Drugs Market Growth 2025-2031
US$ 3,660.00
... the growth prospects of global Mental Illness Drugs market for 2018-2023. This report presents a comprehensive overview, market shares, and growth opportunities of Mental Illness Drugs market by product type, application ...
October 2025
105 pages
Global Neuroprotective Drugs Market Growth 2025-2031
US$ 3,660.00
... being 2017) and the growth prospects of global Neuroprotective Drugs market for 2018-2023. Neuroprotective Drugs consist of medications that can ... the structure of Neuroprotective Drugs market by identifying its various subsegments. Focuses on the key global Neuroprotective Drugs manufacturers, to define ...
October 2025
110 pages
Global Neuroprotective Products Market Growth 2025-2031
US$ 3,660.00
... 2017) and the growth prospects of global Neuroprotective Products market for 2018-2023. Neuroprotective Products consist of medications that ... report presents a comprehensive overview, market shares, and growth opportunities of Neuroprotective Products market by product type, application, key manufacturers and ...
October 2025
141 pages
